Skip to main content

Table 4 The conditions of VPSV and VPSWOV patients when they were discharged from hospital

From: Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

  

VPSV (n = 13)

VPSWOV(n = 10)

P 1

P 2

P

symptoms improved

headache

11/11(100%)

9/10(90%)

<0.001

<0.001

0.476

Visual

5/7(71.4%)

6/7(85.7%)

0.374

0.05

>0.999

Auditory

1/2(50%)

2/3(66.7%)

0.371

0.51

>0.999

Mental change

4/5(80%)

2/3(66.7%)

0.615

0.510

0.464

CSF

CSF pressure (mmH2O) median (range)

100(50–200)

142(90–330)

<0.001

<0.001

0.064

 

WBC count (×106/l) median (range)

26(6–70)

80(25–232)

0.62

0.798

0.281

 

Protein, g/L median (range)

1.27(0.18–4.8)

1.61(0.51–3.98)

0.018

0.002

0.325

 

Glucose(mmol/l) median (range)

1.61(0.69–5)

1.17(0.43–7.45)

0.04

0.312

0.806

 

Chloride(mmol/l) median (range)

124(120–128)

122(115–132)

0.03

0.935

0.166

 

India ink Cryptococcus count

0(0–32)

0(0–5)

0.001

<0.001

0.577

  1. P1 pre-operation versus discharged from hospital in the VPSV group
  2. P2 pre-operation versus discharged from hospital in the VPSWOV group
  3. P VPSV versus VPSWOV at discharge from hospital